CARDIORA
Cardiora is a clinical stage biopharmaceutical company that was established in 2015. Cardiora is focussed on developing new treatments for patients with end stage heart failure, which is associated with high mortality rates, recurrent hospital admissions and poor quality of life. Cardiora’s lead program is currently in Phase Ib trials, and IND enabling trials are currently being completed. Cardiora intends to enter Phase II trials in 2017.
CARDIORA
Industry:
Biopharma Health Care Wellness
Founded:
2015-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.cardiora.com
Total Employee:
11+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Alsonex
Alsonex is a biopharmaceutical company focused on the development of new treatments for neurodegenerative disease.
Trutino Biosciences
Trutino Biosciences is a iopharmaceutical company that develops the next generation cytokine therapies.
Investors List
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Seed Round - Cardiora
Brandon Capital Partners
Brandon Capital Partners investment in Seed Round - Cardiora
More informations about "Cardiora"
Cardiora - Crunchbase Company Profile & Funding
Cardiora is a clinical stage biopharmaceutical company that was established in 2015. Cardiora is focussed on developing new treatments for patients with end stage heart failure, which is …See details»
Cardiora Company Profile 2024: Valuation, Funding & Investors
Cardiora General Information Description. Developer of an oral drug designed to prevent heart failure. The company's oral drug is a compound that has functional outcomes with ensured …See details»
Cardiora - Products, Competitors, Financials, Employees, …
Headquarters Location. 278 Collins Street Level 9. Melbourne, Victoria, 3000, Australia +61 3 9657 0700See details»
Cardiora - Company Profile - Tracxn
May 26, 2024 Cardiora - Orally administered small molecule for end-stage heart failure.. This company is not active anymore. Raised a total funding of $4.15M over 1 round from 1 investor. …See details»
Cardiora Pty Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cardiora Pty Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials.See details»
Cardiora - Funding, Financials, Valuation & Investors - Crunchbase
Jan 1, 2016 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 1, 2016: …See details»
CARDIORA PTY LTD - Profile, contacts and insights - The Grid
Oct 29, 2024 Find key decision-makers, contacts, emails, headcount, share capital, recent funding, IPO status and other insights of CARDIORA PTY LTD.See details»
Cardiora Pty Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Cardiora Pty Ltd including stock price, company news, executives, board members, and contact informationSee details»
Cardiora - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Cardiora is a biopharmaceutical company that is focused on developing new treatments for patients with end stage heart failure.See details»
Home - Cardior
The video illustrates how CDR132L operates in cardiac cells to reverse adverse cardiac remodeling and restore normal cellular functions. CDR132L is currently being evaluated in HF …See details»
Cardiora Release: $9 Million Cash Injection For Two ... - BioSpace
Nov 23, 2015 ..Start-up companies Cardiora and Aravax to receive $9m in venture capital funding to progress development of novel heart failure therapy and peanut allergy vaccineSee details»
THINK AORTA Canada | Think Aorta
Apr 30, 2024 Visit our stand at the AATS Annual Meeting in Toronto - 27-30 April 2024See details»
Novoheart and Sardocor Corporate Divisions | Medera
Founded in 2014, Medera’s Novoheart has an extensive corporate history in commercializing bioengineered human cardiac tissues for disease modeling and drug screening. Our founders …See details»
Projects - Experimental Cardiology Group - Cardiovascular …
We are working in an interdisciplinary, friendly and amazing environment, developing interesting and challenging projects. Our goal is to make this environment accessible for the next …See details»
Cardiology groups find innovative strategies in virtual care | Recora
To care for a growing patient population while navigating staffing constraints and rising costs, independent cardiology groups must rely on innovative strategies without compromising on …See details»
Cardior Pharmaceuticals - Crunchbase Company Profile & Funding
Cardior Pharmaceuticals is a biotechnology company that engages in the development of non-coding RNA based therapeutics for the treatment and prevention of heart disease.See details»
Cardiovascular Workshop - Experimental Cardiology Group
The first Cardiovascular Workshop was successfully held in our institute. Five days of fruitful discussions and learning were going too fast. We expect a such interesting and rich …See details»
The Hearts in Rhythm Organization: A Canadian National …
Contexte : La Hearts in Rhythm Organization (HiRO) est une equipe d’experts canadiens en matière de rythmes cardiaques et de cardio-myopathies hereditaires, de conseillers en …See details»
Cardiola - Crunchbase Company Profile & Funding
Cardiola Ltd. was founded in Switzerland in 2000. The company focuses on research into treatment of chronic heart failure.See details»
Quora - A place to share knowledge and better understand the …
Quora is a place to gain and share knowledge. It's a platform to ask questions and connect with people who contribute unique insights and quality answers. This empowers people to learn …See details»